Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma
Open Access
- 1 December 2017
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 16 (12) , 2711-2723
Abstract
Lycorine is a multifunctional bioactive compound, and it possesses potential anticancer activities. However, little is known about the underlying mechanism. In this research, we have found that lycorine significantly induces the apoptotic and autophagic capacities of hepatocellular carcinoma (HCC) cells in vitro and in vivo. Treatment with specific autophagy inhibitor (3-methyladenine/Bafilomycin A1) or knockdown of LC-3B/Atg5 by siRNA drastically enhances the apoptotic cell death effect by facilitating the switch from autophagy to apoptosis. Molecular validation mechanistically demonstrates that lycorine-induced apoptosis and autophagy in HCC cells is associated with decreased protein levels of tongue cancer resistance–associated protein 1 (TCRP1), and we further find that inhibition of TCRP1 decreases phosphorylation level of Akt and represses Akt/mTOR signaling. Finally, lycorine-induced apoptosis and autophagy suppress the growth of xenograft hepatocellular tumors without remarkable toxicity. Our results elucidate a novel molecular mechanism whereby lycorine promotes apoptosis and autophagy through the TCRP1/Akt/mTOR pathway in HCC. Our results reveal that lycorine might be a potential therapeutic agent for the treatment of HCC. Mol Cancer Ther; 16(12); 2711–23. ©2017 AACR.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81603253)
- National Natural Science Foundation of China (81673703)
- National Natural Science Foundation of China (81602614)
- Natural Science Foundation of Tianjin Municipality (15JCYBJC54900)
- Natural Science Foundation of Tianjin Municipality (15PTCYSY00030)
This publication has 51 references indexed in Scilit:
- Autophagy regulation and its role in cancerSeminars in Cancer Biology, 2013
- Emerging regulation and functions of autophagyNature Cell Biology, 2013
- Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell CarcinomaPLOS ONE, 2012
- Medical therapies for hepatocellular carcinoma: a critical view of the evidenceNature Reviews Gastroenterology & Hepatology, 2012
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJournal of Hepatology, 2012
- Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replicationVirology Journal, 2011
- RETRACTED ARTICLE: TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathwayMolecular and Cellular Biochemistry, 2011
- New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivativesBioorganic & Medicinal Chemistry, 2008
- Diagnosis and Treatment of Hepatocellular CarcinomaGastroenterology, 2008
- Discovery and development of sorafenib: a multikinase inhibitor for treating cancerNature Reviews Drug Discovery, 2006